Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.45 |
| ▸ | WNT3A | P56704 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670168 | 0.90 | PKM (0.58) | PKMCA12CA1CA2CA3 | |
| SCHEMBL15044147 | 0.87 | PKM (0.50) | PKMCA12CA1CA2CA3 | |
| SCHEMBL8461664 | 0.84 | ALDH1A1 (0.50) | CA1CA2PTGS2KMT2AALDH1A1 | |
| SCHEMBL19398376 | 0.83 | PKM (0.50) | PKMCA12CA1CA2CA3 | |
| SCHEMBL15171963 | 0.83 | PKM (0.46) | PKMCA12CA1CA2CA3 | |
| SCHEMBL12396894 | 0.78 | LMNA (0.78) | PKMCA12CA1CA2CA3 | |
| SCHEMBL3230514 | 0.78 | CA12 (0.78) | PKMCA12CA1CA2CA3 | |
| SCHEMBL15242142 | 0.76 | CA1 (0.53) | PKMCA12CA1CA2CA3 | |
| SCHEMBL624796 | 0.76 | PKM (0.58) | PKMCA12CA1CA2CA3 | |
| SCHEMBL402146 | 0.76 | KDM4E (0.55) | PKMCA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275215-A1 | LIGNIN PROCESSING | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275215-A1 | LIGNIN PROCESSING | NOX4, SOD1, LPO | PKM 3081/4885CA12 961/4885CA1 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.